BRAIN Initiative highlighted at NIDA advisory council meeting

Initiative to receive more than $200 million in FY 2014 from federal and private sources.

By Geoff Mumford

The National Institute on Drug Abuse (NIDA) held the fall meeting of its advisory council on Sept. 4, 2013. 

NIDA Director Nora Volkow provided a report (PDF, 5.83MB) highlighting progress on the Obama administration’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. For fiscal year 2014, the initiative includes $110 million in funding from the National Institutes of Health, National Science Foundation and Defense Advanced Research Projects Agency and $122 million from various private institutions. A BRAIN Initiative working group established by NIH Director Francis Collins to identify high priority research areas for that funding discussed an interim report in a public teleconference on Sept. 16.

Additional highlights included presentations on the NIH Initiative to Enhance Reproducibility and Transparency of Research Findings (PDF, 3.67MB) and an update on the Collaborative Research on Addiction at NIH (CRAN) (PDF, 1.55MB). Phil Skolnick, PhD, DSc, provided an overview of NIDA/Industry partnerships (PDF, 2.21MB) with a focus on promising pharmacotherapies for the treatment of cocaine addiction. Ron Valdiserri, MD, MPH, provided an update on viral hepatitis in drug abusing populations (PDF, 883KB), citing the rising incidence of hepatitis C in youth, which now kills more individuals than HIV/AIDS. Joe Frascella, PhD, provided an overview of the current portfolio within the Division of Clinical Neuroscience & Behavioral Research (DCNBR) (PDF, 9.61MB).

For more information on this issue contact Geoff Mumford.